Publicaciones (72) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Correction to: Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (Cancers, (2019), 11, 12, (1984), 10.3390/cancers11121984)

    Cancers

  2. Erratum: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells (British Journal of Nutrition (2008) 100: 5 (968-976) DOI: 10.1017/S0007114508966083)

    British Journal of Nutrition

  3. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation

    Acta Pharmacologica Sinica, Vol. 44, Núm. 5, pp. 1066-1082

  4. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

    Cells, Vol. 12, Núm. 8

  5. Influence of 12-Week Concurrent Training on Exosome Cargo and Its Relationship with Cardiometabolic Health Parameters in Men with Obesity

    Nutrients, Vol. 15, Núm. 13

  6. Neuropilins as potential biomarkers in hepatocel-lular carcinoma: a systematic review of basic and clinical implications

    Clinical and Molecular Hepatology, Vol. 29, Núm. 2, pp. 293-319

  7. Potencial valor pronóstico y diagnóstico de la neuropilina-1 en el carcinoma hepatocelular: relación con la pérdida de sensibilidad al tratamiento con lenvatinib

    Universidad de León

  8. Relationship Between Surface Temperature, Body Composition and Anthropometric Indicators of Obesity and Overweight

    International Journal of Morphology, Vol. 41, Núm. 6, pp. 1824-1832

  9. Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)

    Chinese Clinical Oncology